Discovery set Confirming diagnostic generalization in validation set (HC, 46; MDD, 43; BD, 48) (HC 171; MDD, 122; BD, 169) 16S rRNA gene sequencing 3012 OTUs Filtering OTUs with '0' value > 80% 748 OTUs Shared and distinct OTUs in both MDD and BD groups related to HC group LDA>2.5 FC >2 MDD/HC: 13 OTUs BD/HC: 44 OTUs 4 shared OTUs, remaining OTUs are specific to MDD or BD LDA>2.5 Discriminative microbial markers for MDD, BD and HC group 26 OTUs Random Forest used to quantify the diagnostic performance Higher AUC values in discovery set Figure. S1 Figure. S1. The workflow diagram for this work. Abbreviation: HC, healthy controls; MDD, major depressive disorder; BD, bipolar disorder; OTU, operational taxonomic units; AUC, area under the curve; LEfSe, linear discriminant analysis effect size; FC, fold changes.
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Supplementary Figures
. The workflow diagram for this work. Figure. S2. The influence of potential confounders on overall microbial composition. Figure. S3 . The influence of potential confounder on overall microbial composition. Figure. S4. Discriminative OTUs observed in the pairwise comparisons between the three groups. Figure. S5. Co-occurrence networks deduced from the relative abundance of differential OTUs between MDD and BD. The samples from MDD, BD and HC groups were not clustered based on Body Mass Index. Random Forest analysis was used to quantify the diagnostic performance in discovery set. The samples from discovery set were randomly divided into two groups. The group 1 was composed of 80% of samples from discovery set; the remaining samples were assigned to group 2. In group 1, this microbial panel enabled distinguishing the patients with MDD from those with BD or HCs, yielding a high diagnostic accuracy (MDD versus HC, AUC=0.998; BD versus HC, AUC=0.994;
MDD versus BD, AUC=0.994). The diagnostic efficiency of this microbial classifier was further tested in group 2. Consequently, the diagnostic performance was confirmed with AUC values of at least 0.7 (MDD versus HC, AUC=0.701; BD versus HC, AUC=0.816; MDD versus BD, AUC=0.812;
Group 1: HC, n=122; MDD, n=84; BD, n=118; Group 2: HC, n=49; MDD, n=38;BD, n=51.) Table S1 . Detailed clinical characteristics of the subjects. Table S2 . Discriminatory microbes of family level among MDD, BD and HC groups. Table S3 . Discriminatory operational taxonomic units (OTUs) between MDD and HC groups. 
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